Literature DB >> 24281364

BRCA1/2 mutations and FMR1 alleles are randomly distributed: a case control study.

Efrat Dagan1, Yoram Cohen2, Adi Mory3, Vardit Adir4, Zvi Borochowitz5, Hila Raanani6, Alina Kurolap3, Svetlana Melikhan-Revzin3, Dror Meirow2, Ruth Gershoni-Baruch3.   

Abstract

BRCA mutation carriers were reported to display a skewed distribution of FMR1 genotypes, predominantly within the low normal range (CGG repeat number <26). This observation led to the interpretation that BRCA1/2 mutations are embryo-lethal, unless rescued by 'low FMR1 alleles'. We undertook to re-explore the distribution of FMR1 alleles subdivided into low, normal and high (<26, 26-34, and >34 CGG repeats, respectively) subgenotypes, on a cohort of 125 Ashkenazi women, carriers of a BRCA1/2 founder mutation. Ashkenazi healthy females (n=368), tested in the frame of the Israeli screening population program, served as controls. BRCA1/2 carriers and controls demonstrated a comparable and non-skewed FMR1 subgenotype distribution. Taken together, using a homogeneous ethnic group of Ashkenazi BRCA1/2 mutation carriers, we could not confirm the reported association between FMR1 low genotypes and BRCA1/2 mutations. The notion that BRCA1/2 mutations are embryo-lethal unless rescued by the low FMR1 subgenotypes is hereby refuted.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24281364      PMCID: PMC3895656          DOI: 10.1038/ejhg.2013.281

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  17 in total

1.  Analysis of germline variation at the FMR1 CGG repeat shows variation in the normal-premutated borderline range.

Authors:  E Mornet; C Chateau; M C Hirst; F Thepot; A Taillandier; O Cibois; J L Serre
Journal:  Hum Mol Genet       Date:  1996-06       Impact factor: 6.150

2.  BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancer.

Authors:  R Gershoni-Baruch; E Dagan; G Fried; I Kepten; E Robinson
Journal:  Eur J Hum Genet       Date:  1999 Oct-Nov       Impact factor: 4.246

3.  Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks.

Authors:  Kutluk Oktay; Ja Yeon Kim; David Barad; Samir N Babayev
Journal:  J Clin Oncol       Date:  2009-12-07       Impact factor: 44.544

4.  Ovarian reserve determinations suggest new function of FMR1 (fragile X gene) in regulating ovarian ageing.

Authors:  Norbert Gleicher; Andrea Weghofer; David H Barad
Journal:  Reprod Biomed Online       Date:  2010-03-01       Impact factor: 3.828

5.  Direct detection of mutations in the breast and ovarian cancer susceptibility gene BRCA1 by PCR-mediated site-directed mutagenesis.

Authors:  E M Rohlfs; W G Learning; K J Friedman; F J Couch; B L Weber; L M Silverman
Journal:  Clin Chem       Date:  1997-01       Impact factor: 8.327

6.  Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve.

Authors:  Norbert Gleicher; Andrea Weghofer; Kutluk Oktay; David Barad
Journal:  Reprod Biomed Online       Date:  2009-09       Impact factor: 3.828

7.  A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone.

Authors:  Norbert Gleicher; Andrea Weghofer; David H Barad
Journal:  Fertil Steril       Date:  2008-04-02       Impact factor: 7.329

8.  Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.

Authors:  Mary-Claire King; Joan H Marks; Jessica B Mandell
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

9.  Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: a new infertility test?

Authors:  Norbert Gleicher; Andrea Weghofer; Kutluk Oktay; David H Barad
Journal:  Acta Obstet Gynecol Scand       Date:  2009       Impact factor: 3.636

10.  Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers.

Authors:  Eitan Friedman; Joanne Kotsopoulos; Jan Lubinski; Henry T Lynch; Parviz Ghadirian; Susan L Neuhausen; Claudine Isaacs; Barbara Weber; William D Foulkes; Pal Moller; Barry Rosen; Charmaine Kim-Sing; Ruth Gershoni-Baruch; Peter Ainsworth; Mary Daly; Nadine Tung; Andrea Eisen; Olufunmilayo I Olopade; Beth Karlan; Howard M Saal; Judy E Garber; Gad Rennert; Dawna Gilchrist; Charis Eng; Kenneth Offit; Michael Osborne; Ping Sun; Steven A Narod
Journal:  Breast Cancer Res       Date:  2006-03-21       Impact factor: 6.466

View more
  5 in total

Review 1.  The impact of FMR1 gene mutations on human reproduction and development: a systematic review.

Authors:  Vincenzo Noto; Conor Harrity; David Walsh; Kevin Marron
Journal:  J Assist Reprod Genet       Date:  2016-07-18       Impact factor: 3.412

2.  Is Low FMR1 CGG Repeat Length in Males Correlated with Family History of BRCA-Associated Cancers? An Exploratory Analysis of Medical Records.

Authors:  Hallee C Adamsheck; Elizabeth M Petty; Jinkuk Hong; Mei W Baker; Murray H Brilliant; Marsha R Mailick
Journal:  J Genet Couns       Date:  2017-06-30       Impact factor: 2.537

3.  Association between hereditary predisposition to common cancers and congenital multimalformations.

Authors:  Fabrice Kwiatkowski; Isabelle Perthus; Nancy Uhrhammer; Christine Francannet; Marie Arbre; Yannick Bidet; Yves-Jean Bignon
Journal:  Congenit Anom (Kyoto)       Date:  2019-03-12       Impact factor: 1.409

4.  Absence of BRCA/FMR1 correlations in women with ovarian cancers.

Authors:  Norbert Gleicher; Jessica N McAlpine; C Blake Gilks; Vitaly A Kushnir; Ho-Joon Lee; Yan-Guang Wu; Emanuela Lazzaroni-Tealdi; David H Barad
Journal:  PLoS One       Date:  2014-07-18       Impact factor: 3.240

5.  Reduction in the number of CGG repeats on the FMR1 gene in carriers of genetic disorders versus noncarriers.

Authors:  Alexandra Peyser; Tomer Singer; Christine Mullin; Avner Hershlag
Journal:  JBRA Assist Reprod       Date:  2017-12-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.